- Type
- Exempt offering
- Amount
- $6.4M
- Date
- June 26, 2025
- Location
- Plymouth, Minnesota
- Sectors
- Biotechnology
Reprise Biomedical, Inc., of Plymouth, MN, reported $6.4M sold in an offering exempt from registration under Regulation D. The total offering was stated as $7M (91% of the stated offering).
The issuer classified itself under Biotechnology on the filing and is organized as a corporation.
Form D does not identify who invested — it records the issuer, the amount, and the exemption claimed. Investor names are therefore left blank rather than guessed at, and the filing carries no round label, so none is assigned here.
Sources
- SEC Form D — Reprise Biomedical, Inc., accession 0001782236-25-000003 — retrieved August 7, 2026